CBCameron J. Brace

Cameron J. Brace

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cameron J. Brace has a total of 39 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Frequent cannabis use and the association with seizure burden in drug‐resistant epilepsy

    by Santiago Philibert‐Rosas, Kaitlin A. Guston, Mariel Kalkach‐Aparicio, Abigail Keller, Sanaa Semia, Theodore Imhoff‐Smith, Cameron J. Brace, Steven E. Haworth, Felipe Branco de Paiva, Dace Almane, et al.

    Objective: Cannabis use has increased substantially, with modern products characterized by high tetrahydrocannabinol concentrations and variable composition. The relationship between frequent cannabis use and epilepsy outcomes remains uncertain. We examined the association between frequent cannabis use and epilepsy severity, clinical phenotype, and imaging characteristics in patients admitted to an epilepsy monitoring unit (EMU). Methods: This retrospective cohort study included adults with drug‐resistant epilepsy admitted to a tertiary care EMU. Patients were classified based on cannabis use documented in the electronic medical record over the year prior to admission. Frequent use was defined as cannabis use on ≥20 days/month; patients with low use were excluded. Primary outcomes included markers of epilepsy severity, including time from epilepsy onset to EMU admission, presence and frequency of focal to bilateral tonic–clonic seizures (FBTCS), and antiseizure medication (ASM) burden. Secondary analyses evaluated epilepsy syndrome and mesial temporal lobe volumetric measures. Results: Sixty‐four patients were included (42 nonusers and 22 frequent users). Frequent cannabis use was associated with shorter time from epilepsy onset to EMU admission (mean [SD] = 5.0 [4.2] vs. 18.1 [16.3] years, p = .004), higher prevalence of FBTCS (90.9% vs. 57.1%, p = .04), greater annualized FBTCS frequency (mean [SD] = 3.00 [3.63] vs. 1.32 [3.87], p = .003), and higher ASM burden (mean [SD] = 3.05 [1.00] vs. 2.21 [1.14], p = .027). All frequent cannabis users had temporal lobe epilepsy (TLE), although the between‐group difference in TLE prevalence was not statistically significant. No significant group differences were observed in imaging analysis. Significance: In this cohort of patients with drug‐resistant epilepsy, frequent cannabis use was associated with markers of increased epilepsy severity, including higher FBTCS burden, shorter time to specialized EMU evaluation, and greater ASM requirements. Prospective studies using objective cannabis exposure measures are needed to clarify the relationship between cannabis use and epilepsy outcomes.

  • Clinical and imaging correlates of lateralized rhythmic delta activity: A multicenter cohort study

    by Sophia Muqaddas, Zade Akras, Kaileigh Gallagher, Marjan Sarami, Ali Han Yaramis, Imad Akbar, Zeeshan Haider, Justin Wheelock, Cameron J. Brace, Santiago Philibert-Rosas, et al.

  • Open Access

    Neural Signatures of Conscious Experience During Sleep: A Serial Awakening Study Using High-Density EEG

    by Atakan Selte, Steven E. Haworth, Thomas Vanasse, Tariq Alauddin, Klevest Gjini, Santiago Philibert-Rosas, Cameron J. Brace, Brinda Sevak, Brady Riedner, Mariel Kalkach Aparicio, et al.

    Identifying neural signatures of consciousness remains a central challenge in neuroscience. Sleep offers a tractable model for comparing brain activity in the presence or absence of subjective experience while minimizing behavioral responsiveness confounds. Using overnight 256-electrode high-density EEG in 140 participants and a serial-awakening paradigm, we analyzed 699 non-rapid eye movement (NREM) sleep stage 2 and 3 awakenings (351 dreaming experience, 348 no experience). Features from the 60s preceding awakening included regional spectral power, lagged-coherence connectivity, graph-theoretic metrics and gamma-to-alpha power ratios. Dreaming experiences were associated with shifts in posterior spectral balance, particularly reduced alpha and delta power and increased gamma-related measures, together with altered large-scale network organization. In participant-level cross-validated machine-learning analyses, all classifiers performed above chance, with the best ensemble model reaching an ROC-AUC of 0.80 and average precision of 0.80. These findings identify reproducible posterior electrophysiological and network-level signatures of conscious states during NREM sleep.

  • Open Access

    Duration of EEG monitoring needed to ensure a low risk of seizure recurrence in hospitalized patients

    by Parimala Velpula Krishnamurthy, Santiago Philibert-Rosas, Maxwell Rivkin, Cameron J. Brace, Steven E. Haworth, Safoora Fatima, Atakan Selte, Mariel Kalkach Aparicio, Aaron F. Struck

    Background: Continuous EEG (cEEG) monitoring is critical for detecting seizures in hospitalized patients, but optimal durations of EEG monitoring remain unclear, particularly after a seizure has been detected on monitoring. Methods: We conducted survival analysis on 117 patients with electrographic or electroclinical seizures who underwent cEEG at the University of Wisconsin Hospital (UWH) between 2018 and 2022. Time from the end of seizure-to-seizure recurrence or cEEG termination was analyzed using Cox regression. Results: In univariate analysis, status epilepticus (SE) was the only clinical feature significantly associated with increased risk of seizure recurrence ( P = 0.022). The estimated EEG duration required to reduce seizure recurrence risk below 5% was 36.8 h in patients with SE and 21.2 h in those without SE. Numerous other clinical variables, including coma, antiseizure medications addition, use of anesthetic infusions, history of epilepsy, and epileptiform discharges, were not significant. Conclusion: Our findings support current clinical practices of at least 24 h of EEG monitoring following seizure cessation and highlight that patients with a history of status epilepticus may require longer monitoring. These data reinforce the value of individualized, risk-based approaches to EEG monitoring strategies.